A lovely review of some of the things that we have done over the past 7 years @preventiveneur1.bsky.social It’s been a real privilege and joy to do this with our team. Huge thanks to Bart’s Charity for the belief and support. www.bartscharity.org.uk/our-news/gro...

Ground-breaking research at the Centre for Preventive Neurology

In 2017, we funded the Preventive Neurology Unit, which has since expanded to become a Centre - the first of its kind in the UK.

bartscharity.org.uk

It's been a busy time in the MS group in the Centre for Preventive Neurology! We've put together a newsletter to update where we're up to, opportunities to input into and take part in research, and highlight some of our fantastic PhD students. mailchi.mp/4672ff6ce37d...

First of 8 parkruns in 15 days for us - this one definitely had an over-representation of Professors of Neurology/Neuroscience (I counted 3)

A paper to be proud of from a fab team. ocrelizumab pregnancy registry data, with over 3000 recorded pregnancies, >800 treated within 3 months of pregnancy and >500 of those with outcomes. We need this kind of data to improve shared decision making around pregnancy. www.neurology.org/doi/10.1212/...

Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab | Neurology Neuroimmunology & Neuroinflammation

Background and ObjectivesOcrelizumab labeling advises contraception for women during treatment and for 6–12 months thereafter. Because pregnancies may occur during this time, it is critical to underst...

neurology.org

It’s not been the greatest couple of weeks at work for various reasons (although lots of exciting things just starting to fall into place, so hopefully a temporary blip). The practice for my back up career is going ok though

So pleased (relieved?) to see these out. We’ve tried to really nail down consensus principles that actually mean something in clinical practice. The result of lots of hard work by many, particularly Waqar Rashid. pn.bmj.com/content/earl...

Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance

The Association of British Neurologists last published guidelines on disease-modifying treatment (DMT) in multiple sclerosis (MS) in 2015. Since then, additional DMTs have been licensed and approved f...

pn.bmj.com

🧪ACTRIMS’ partner organization, International Women in Multiple Sclerosis (iWiMS), is providing 5 travel grants to investigators with young children to cover the costs of childcare during #ACTRIMS2025. Apply here: fs2.formsite.com/1FItkk/w3t1c...

iWiMS Parental Grant

View this form on Formsite

fs2.formsite.com

Really excited to be coming to San Diego and sharing the stage with you both - it should be a great session!

Dr. Jaime Imitola, MD FAAN@drjim4ms.bsky.social · 2y ago

Please share, join us at the @AANmember 2025 annual meeting, in San Diego. Course C147 #Dx and #Tx in #MS in #diverse #populations with @drruthdobson and @LilyanaAmezcua @drjim4ms .bsky.social

Trying to work out this new platform… tricky to know how to start…